Kurma Partners
Fiche investisseur | Builders Republic
À propos
Kurma Partners is a major European Venture Capital firm strictly specialized in Life Sciences. Founded in 2009, it is renowned for its "Company Creation" model: rather than just selecting existing startups, Kurma actively partners with top academic research centers (like Institut Pasteur or CNRS) to identify scientific breakthroughs and build companies from scratch around them. Since 2024, Kurma has been fully integrated into the Eurazeo group (as their dedicated Healthcare arm), giving them increased financial firepower while maintaining their operational independence. They operate three distinct strategies: Biofund (Therapeutics), Diagnostics (Digital Health & Dx), and Growth (Late-stage scale-ups).
Informations clés
- Type
- Venture Capital
- Stades
- Pre-Seed,Seed,Series A,Series B,Growth
- Secteurs
- Healthcare,Digital health
- Siège
- France
- Bureaux
- Paris,Munich
- Focus géographique
- France,Europe
- Lead / Follow
- Lead / co-lead
- Ticket
- 2M€ – 10M€
- Actifs sous gestion
- 890M€
- Fondé en
- 2009
Track Record
- Sociétés en portefeuille : 52
- Investissements totaux : 72
- Exits : 8
- Unicorns : 2
Investissements notables en France
Imcheck Therapeutics, Charles, Ganymed Robotics
Points différenciants
Sector Specialist,Multi-stage,PE-backed,Company Builder